{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T09:28:30Z","timestamp":1785403710249,"version":"3.56.0"},"reference-count":52,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Medical University of Warsaw, Poland"},{"name":"European Union"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Background:\u00a0Cannabis sativa L. and its products are becoming popular for the treatment of inflammatory diseases. One of the main phytocannabinoids contained in cannabis is cannabidiol (CBD), which is a component of numerous cosmetic preparations used to treat inflammatory skin diseases such as atopic dermatitis (AD) and psoriasis. However, current data regarding the efficacy and safety of CBD for dermatological indications are limited. Therefore, the aim of the present study was to evaluate the anti-inflammatory effect of high-CBD Cannabis sativa L. extract (eCBD) in a model of AD. Methods: Dermatitis was induced by repeated application of 2,4-dinitrochlorobenzene (DNCB) to the skin of the rats\u2019 ears. The therapeutic effect of eCBD was evaluated in behavioral, histopathological, and hematological studies following topical application as an ointment containing 2% CBD. Results: Application of the ointment containing eCBD resulted in attenuation of DNCB-induced inflammation. Interestingly, an anti-edematous effect was more pronounced in rats treated with the eCBD than in rats treated with 1% hydrocortisone ointment. However, eCBD did not reduce the frequency of DNCB-induced scratching, while there was a visible antipruritic effect of 1% hydrocortisone application. Histopathological analysis revealed that both eCBD and 1% hydrocortisone ointments significantly decreased mast cell count compared with the Vaseline control group. Furthermore, treatment with an ointment containing eCBD resulted in a decrease in the number of leukocytes in the blood. Conclusions: Topically administered eCBD had a stronger anti-edematous effect than glucocorticosteroid and differently affected hematological parameters. It is suggested that eCBD has therapeutic potential for the treatment of AD.<\/jats:p>","DOI":"10.3390\/ph18030370","type":"journal-article","created":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T03:18:22Z","timestamp":1741144702000},"page":"370","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Anti-Inflammatory Activity of Cannabis sativa L. Extract in 2,4-Dinitrochlorobenzene-Induced Dermatitis in Rats"],"prefix":"10.3390","volume":"18","author":[{"given":"Renata","family":"Woli\u0144ska","sequence":"first","affiliation":[{"name":"Department of Pharmacotherapy and Pharmaceutical Care, Faculty of Pharmacy, Medical University of Warsaw, Banacha 1, 02-097 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Zalewska","sequence":"additional","affiliation":[{"name":"Department of Pharmacotherapy and Pharmaceutical Care, Faculty of Pharmacy, Medical University of Warsaw, Banacha 1, 02-097 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1321-2235","authenticated-orcid":false,"given":"Piotr","family":"Pozna\u0144ski","sequence":"additional","affiliation":[{"name":"Department of Experimental Genomics, Institute of Genetics and Animal Biotechnology, Polish Academy of Science, Post\u0119pu 36A, 05-552 Jastrz\u0119biec, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2806-6194","authenticated-orcid":false,"given":"Agata","family":"Nawrocka","sequence":"additional","affiliation":[{"name":"Department of Experimental Genomics, Institute of Genetics and Animal Biotechnology, Polish Academy of Science, Post\u0119pu 36A, 05-552 Jastrz\u0119biec, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Kowalczyk","sequence":"additional","affiliation":[{"name":"Department of Pharmacotherapy and Pharmaceutical Care, Faculty of Pharmacy, Medical University of Warsaw, Banacha 1, 02-097 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariusz","family":"Sacharczuk","sequence":"additional","affiliation":[{"name":"Department of Pharmacotherapy and Pharmaceutical Care, Faculty of Pharmacy, Medical University of Warsaw, Banacha 1, 02-097 Warsaw, Poland"},{"name":"Department of Experimental Genomics, Institute of Genetics and Animal Biotechnology, Polish Academy of Science, Post\u0119pu 36A, 05-552 Jastrz\u0119biec, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Bujalska-Zadro\u017cny","sequence":"additional","affiliation":[{"name":"Department of Pharmacotherapy and Pharmaceutical Care, Faculty of Pharmacy, Medical University of Warsaw, Banacha 1, 02-097 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,3,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"S128","DOI":"10.1016\/j.jaci.2003.09.032","article-title":"Immune mechanisms leading to atopic dermatitis","volume":"112","author":"Novak","year":"2003","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s40257-015-0171-3","article-title":"Quality of Life in Patients with Atopic Dermatitis: Disease Burden, Measurement, and Treatment Benefit","volume":"17","author":"Blome","year":"2016","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/978-3-319-64804-0_3","article-title":"Atopic Dermatitis: Pathophysiology","volume":"1027","author":"Tarbox","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Ruzicka, T., Ring, J., and Przybilla, B. (1991). Histopathological and Immunohistological Aspects of Atopic Eczema. Handbook of Atopic Eczema, Springer.","DOI":"10.1007\/978-3-662-02671-7"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0091-6749(95)70049-8","article-title":"Atopic dermatitis: The skin as a window into the pathogenesis of chronic allergic diseases","volume":"96","author":"Leung","year":"1995","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"125","DOI":"10.5021\/ad.2010.22.2.125","article-title":"Atopic dermatitis","volume":"22","author":"Bieber","year":"2010","journal-title":"Ann. Dermatol."},{"key":"ref_7","first-page":"523","article-title":"Treatment options for atopic dermatitis","volume":"75","author":"Buys","year":"2007","journal-title":"Am. Fam. Physician"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Reitamo, S., Luger, T.A., and Steinhoff, M. (2008). Antihistamines in atopic dermatitis. Textbook of Atopic Dermatitis, Informa UK Ltd.","DOI":"10.3109\/9780203091449"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jdermsci.2006.10.009","article-title":"Cannabinoids inhibit human keratinocyte proliferation through a non-CB1\/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis","volume":"45","author":"Wilkinson","year":"2007","journal-title":"J. Dermatol. Sci."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.fitote.2010.04.009","article-title":"Comparative topical anti-inflammatory activity of cannabinoids and cannabivarins","volume":"81","author":"Tubaro","year":"2010","journal-title":"Fitoterapia"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1111\/all.12183","article-title":"Anti-inflammatory activity of topical THC in DNFB-mediated mouse allergic contact dermatitis independent of CB1 and CB2 receptors","volume":"68","author":"Gaffal","year":"2013","journal-title":"Allergy"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1152\/physrev.00002.2016","article-title":"From Phytocannabinoids to Cannabinoid Receptors and Endocannabinoids: Pleiotropic Physiological and Pathological Roles Through Complex Pharmacology","volume":"96","author":"Ligresti","year":"2016","journal-title":"Physiol. Rev."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Martinez Naya, N., Kelly, J., Corna, G., Golino, M., Abbate, A., and Toldo, S. (2023). Molecular and Cellular Mechanisms of Action of Cannabidiol. Molecules, 28.","DOI":"10.3390\/molecules28165980"},{"key":"ref_14","first-page":"S31","article-title":"Anti-inflammatory effects of cannabinoids","volume":"6","author":"Marinho","year":"2023","journal-title":"Braz. J. Pain"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1055\/a-1420-5780","article-title":"Cannabis sativa and Skin Health: Dissecting the Role of Phytocannabinoids","volume":"88","author":"Martinelli","year":"2022","journal-title":"Planta Med."},{"key":"ref_16","first-page":"208","article-title":"Use of a palmitoylethanolamide-containing nonsteroidal cream for treating atopic dermatitis: Impact on the duration of response and time between flares","volume":"20","year":"2007","journal-title":"Cosmet. Dermatol."},{"key":"ref_17","first-page":"13030","article-title":"Assessing the Effects of Topical Cannabidiol in Patients with Atopic Dermatitis","volume":"27","author":"Maghfour","year":"2021","journal-title":"Dermatol. Online J."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"988","DOI":"10.2460\/ajvr.73.7.988","article-title":"Cannabinoid receptor type 1 and 2 expression in the skin of healthy dogs and dogs with atopic dermatitis","volume":"73","author":"Campora","year":"2012","journal-title":"Am. J. Vet. Res."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Abramo, F., Campora, L., Albanese, F., della Valle, M.F., Cristino, L., Petrosino, S., Di Marzo, V., and Miragliotta, V. (2014). Increased levels of palmitoylethanolamide and other bioactive lipid mediators and enhanced local mast cell proliferation in canine atopic dermatitis. BMC Vet. Res., 10.","DOI":"10.1186\/1746-6148-10-21"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.jaci.2013.12.1032","article-title":"The expression of cannabinoid receptor 1 is significantly increased in atopic patients","volume":"133","author":"Eiwegger","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Chiocchetti, R., De Silva, M., Aspidi, F., Cunha, R.Z., Gobbo, F., Tagliavia, C., Sarli, G., and Morini, M. (2022). Distribution of Cannabinoid Receptors in Keratinocytes of Healthy Dogs and Dogs with Atopic Dermatitis. Front. Vet. Sci., 9.","DOI":"10.3389\/fvets.2022.915896"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Chiocchetti, R., Salamanca, G., De Silva, M., Gobbo, F., Aspidi, F., Cunha, R.Z., Galiazzo, G., Tagliavia, C., Sarli, G., and Morini, M. (2022). Cannabinoid receptors in the inflammatory cells of canine atopic dermatitis. Front. Vet. Sci., 9.","DOI":"10.3389\/fvets.2022.987132"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.clindermatol.2018.11.002","article-title":"The growing trend of cannabidiol in skincare products","volume":"37","author":"Jhawar","year":"2019","journal-title":"Clin. Dermatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"102552","DOI":"10.1016\/j.ctim.2020.102552","article-title":"Perceptions and recommendation behaviors of dermatologists for medical cannabis: A pilot survey","volume":"55","author":"Yeroushalmi","year":"2020","journal-title":"Complement. Ther. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1124\/jpet.117.244368","article-title":"Anti-inflammatory Properties of Cannabidiol, a Nonpsychotropic Cannabinoid, in Experimental Allergic Contact Dermatitis","volume":"365","author":"Petrosino","year":"2018","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Casares, L., Garc\u00eda, V., Garrido-Rodr\u00edguez, M., Mill\u00e1n, E., Collado, J.A., Garc\u00eda-Mart\u00edn, A., Pe\u00f1arando, J., Calzado, M.A., de la Vega, L., and Mu\u00f1oz, E. (2020). Cannabidiol induces antioxidant pathways in keratinocytes by targeting BACH1. Redox Biol., 28.","DOI":"10.1016\/j.redox.2019.101321"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/DER.0000000000000722","article-title":"Anti-inflammatory Effect of Cannabidiol and Palmitoylethanolamide Containing Topical Formulation on Skin in a 12-O-Tetradecanoylphorbol-13-Acetate-Induced Dermatitis Model in Mice","volume":"33","author":"Rundle","year":"2022","journal-title":"Dermatitis"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1002\/ptr.6400","article-title":"Cannabis sativa L. extract and cannabidiol inhibit in vitro mediators of skin inflammation and wound injury","volume":"33","author":"Sangiovanni","year":"2019","journal-title":"Phytother. Res."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Massimini, M., Dalle Vedove, E., Bachetti, B., Di Pierro, F., Ribecco, C., D\u2019Addario, C., and Pucci, M. (2021). Polyphenols and Cannabidiol Modulate Transcriptional Regulation of Th1\/Th2 Inflammatory Genes Related to Canine Atopic Dermatitis. Front. Vet. Sci., 8.","DOI":"10.3389\/fvets.2021.606197"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"329-e77","DOI":"10.1111\/vde.13077","article-title":"The effect of a mixed cannabidiol and cannabidiolic acid based oil on client-owned dogs with atopic dermatitis","volume":"33","author":"Loewinger","year":"2022","journal-title":"Vet. Dermatol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Mariga, C., Souza Silva Mateus, A.L., Dos Santos Dullius, \u00c2.I., da Silva, A.P., Martins Flores, M., Vasconcelos Soares, A., Amazonas, E., and Tadeu Lemos Pinto Filho, S. (2023). Dermatological evaluation in dogs with atopic dermatitis treated with full-spectrum high cannabidiol oil: A pre study part 1. Front. Vet. Sci., 10.","DOI":"10.3389\/fvets.2023.1285384"},{"key":"ref_32","first-page":"423","article-title":"Effects of Cannabidiol Without Delta-9-Tetrahydrocannabinol on Canine Atopic Dermatitis: A Retrospective Assessment of 8 Cases","volume":"63","author":"Mogi","year":"2022","journal-title":"Can. Vet. J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.36849\/JDD.2020.5464","article-title":"An Observational Study of the Application of a Topical Cannabinoid Gel on Sensitive Dry Skin","volume":"19","author":"Maghfour","year":"2020","journal-title":"J. Drugs Dermatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1111\/ced.14749","article-title":"Tolerability profile of topical cannabidiol and palmitoylethanolamide: A compilation of single-centre randomized evaluator-blinded clinical and in\u2009vitro studies in normal skin","volume":"46","author":"Maghfour","year":"2021","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_35","first-page":"e93","article-title":"A therapeutic effect of cbd-enriched ointment in inflammatory skin diseases and cutaneous scars","volume":"170","author":"Palmieri","year":"2019","journal-title":"Clin. Ter."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1111\/jocd.14263","article-title":"Novel cannabidiol aspartame combination treatment (JW-100) significantly reduces ISGA score in atopic dermatitis: Results from a randomized double-blinded placebo-controlled interventional study","volume":"21","author":"Gao","year":"2022","journal-title":"J. Cosmet. Dermatol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e15064","DOI":"10.1111\/exd.15064","article-title":"Cannabinoids for the treatment of autoimmune and inflammatory skin diseases: A systematic review","volume":"33","author":"Kuzumi","year":"2024","journal-title":"Exp. Dermatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s40257-024-00891-y","article-title":"The Potential Role of Cannabidiol in Cosmetic Dermatology: A Literature Review","volume":"25","author":"Kuzumi","year":"2024","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"84","DOI":"10.2500\/aap.2019.40.4202","article-title":"Pathophysiology of atopic dermatitis: Clinical implications","volume":"40","author":"Kim","year":"2019","journal-title":"Allergy Asthma Proc."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Kader, H.A., Azeem, M., Jwayed, S.A., Al-Shehhi, A., Tabassum, A., Ayoub, M.A., Hetta, H.F., Waheed, Y., Iratni, R., and Al-Dhaheri, A. (2021). Current Insights into Immunology and Novel Therapeutics of Atopic Dermatitis. Cells, 10.","DOI":"10.3390\/cells10061392"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.coi.2009.09.006","article-title":"Mast cells in atopic dermatitis","volume":"21","author":"Kawakami","year":"2009","journal-title":"Curr. Opin. Immunol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/09546630510035832","article-title":"Efficacy of dietary hempseed oil in patients with atopic dermatitis","volume":"16","author":"Callaway","year":"2005","journal-title":"J. Dermatolog Treat."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2147\/ITT.S263690","article-title":"Cannabidiol as a Novel Therapeutic for Immune Modulation","volume":"9","author":"Peyravian","year":"2020","journal-title":"Immunotargets Ther."},{"key":"ref_44","first-page":"99","article-title":"Cannabidiol-induced lymphopenia does not involve NKT and NK cells","volume":"60","author":"Jankowski","year":"2009","journal-title":"J. Physiol. Pharmacol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"105483","DOI":"10.1016\/j.rvsc.2024.105483","article-title":"Investigation of the in vitro effects of cannabidiol, cannabidiolic acid, and the terpene \u03b2-caryophyllene on lymphocytes harvested from atopic and healthy dogs: A preliminary study","volume":"182","author":"Jani","year":"2025","journal-title":"Res. Vet. Sci."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/sj.bjp.0707133","article-title":"Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro","volume":"150","author":"Thomas","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/sj.bjp.0707442","article-title":"The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: \u03949-tetrahydrocannabinol, cannabidiol and \u03949-tetrahydrocannabivarin","volume":"153","author":"Pertwee","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.bcp.2008.06.022","article-title":"The profile of immune modulation by cannabidiol (CBD) involves deregulation of nuclear factor of activated T cells (NFAT)","volume":"76","author":"Kaplan","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"ref_49","unstructured":"Fehlig, P., Baxter, J.D., and Frohman, L.A. (2024, October 29). The Adrenal Cortex, Endocrinology and Metabolism, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK26\/box\/&id\/."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Riedl, R., K\u00fchn, A., Rietz, D., Hebecker, B., Glowalla, K.G., Peltner, L.K., Jordan, P.M., Werz, O., Lorkowski, S., and Wiegand, C. (2023). Establishment and Characterization of Mild Atopic Dermatitis in the DNCB-Induced Mouse Model. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241512325"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1159\/000235551","article-title":"Characterization of a 2,4-dinitrochlorobenzene-induced chronic dermatitis model in rats","volume":"22","author":"Fujii","year":"2009","journal-title":"Skin. Pharmacol. Physiol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/jps.2600800203","article-title":"Species differences in percutaneous absorption of nicorandil","volume":"80","author":"Sato","year":"1991","journal-title":"J. Pharm. Sci."}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/18\/3\/370\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:47:25Z","timestamp":1760028445000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/18\/3\/370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,5]]},"references-count":52,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["ph18030370"],"URL":"https:\/\/doi.org\/10.3390\/ph18030370","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,5]]}}}